▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #994 by analyst upside · 2026-09-28
ANL
Adlai Nortye Group Ltd.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+90.0%
implied upside to consensus target
Current Price $15.53
Consensus Target $29.5
Bull Target $49.0
Bear Target $20.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
6
Hold
0
Sell
0
52-Week Low $0.88
52-Week High $17.25
YTD Return +1025.4%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.66
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $18M
Profit Margin -124.8%
52-WEEK RANGE
52-Week Low $0.88
52-Week High $17.25
Current Price $15.53
Bear Target $20.0
Bull Target $49.0
● Now $15.53 ● Target $29.5
TRADING DATA
Avg Volume 192K
YTD Return +1025.4%
Analyst Count 6
Consensus Buy
Upside to Target +90.0%
Last Updated 2026-09-28

ANALYST SUMMARY

Adlai Nortye Group Ltd. (ANL) is currently trading at $15.53 with a Wall Street consensus price target of $29.5, implying potential upside of 90.0% over the next 12 months. 6 analysts currently cover ANL, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $49.0, while the most cautious has a target of $20.0.

ANL operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 1025.4% year-to-date and is currently trading near the upper end of its 52-week range of $0.88 – $17.25.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ANL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Jefferies ● Initiated
Buy 2026-09-10 50% win rate (6 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-09-08 31% win rate (48 calls)
Cantor Fitzgerald ● Initiated
Overweight 2026-06-22 40% win rate (10 calls)
Oppenheimer ● Initiated
Outperform 2026-05-28 14% win rate (7 calls)
Jones Trading ● Initiated
Buy 2026-05-14 57% win rate (14 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-04-20 31% win rate (48 calls)
HC Wainwright & Co. ↑ Upgrade
Neutral → Buy 2026-02-13 31% win rate (48 calls)
HC Wainwright & Co. ↓ Downgrade
Buy → Neutral 2025-06-02 31% win rate (48 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
15/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →